Publication
Article
BioPharm International
BioPharm International-02-01-2002Volume15 Issue 2
Pages: 52-56
Inside Washington: Costs and Controls Challenge Manufacturers
Author(s):
By Jill Wechsler, pp. 52-56. More curbs on reimbursement for expensive, cutting-edge therapies may shape R&D programs and industry growth
Articles in this issue
Using a Model and Tools to Standardize the Preparation for a Preapproval Inspection
Sale of Your Product Can Prevent Patenting: How to Avoid the On-Sale Bar
Outsourcing Outlook: Reaping the Benefits of E-Procurement
The Immunogenicity of Therapeutic Proteins
Analytical Advances: Calibration Management of Outsourced Calibrations
High-Throughput Biopharmaceutical Drug Development: Meeting the Coming Challenge
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
